The development of cell membrane-modified biomimetic nanoparticles has extensively
increased during the past years due to their exceptional biocompatibility, evasion from the …

Cardiovascular diseases (CVDs) are a primary cause of death globally. A few classic and
hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness …

Most patients are at high risk of thrombosis during cancer treatment. However, the major
discrepancy in the therapeutic mechanisms and microenvironment between tumors and …

Ischemic stroke is one of the major causes of death and disability worldwide, and an
effective and timely treatment of ischemic stroke has been a challenge because of the …

Due to the mortality associated with thrombosis and its high recurrence rate, there is a need
to investigate antithrombotic approaches. Noninvasive site-specific thrombolysis is a current …

Ulcerative colitis (UC) is a chronic or relapsing inflammatory disease with limited therapeutic
outcomes. Pterostilbene (PSB) is a polyphenol-based anti-oxidant that has received …

Ischemic stroke is a vascular central nervous system (CNS) disease that leads a disability
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …

A thrombus is a blood clot that forms in the lumen of an artery or vein, restricting blood flow
and causing clinical symptoms. Thrombosis is associated with many life‐threatening …

Atherosclerosis (AS) is a chronic inflammatory vascular disease. Myocardial ischemia
originated from AS is the main cause of cardiovascular diseases, one of the major factors …

Biomimetic nano-platforms have attracted extensive attention due to their good
biocompatibility, low immunogenicity, and homologous targeting to lesions. In this study …